Heat Biologics, Inc. Skyrocketed

Heat Biologics, Inc. (HTBX:NASDAQ) jumped higher at $3.62, representing a gain of 47.2%. On Fri 17 Jul 20, HTBX:NASDAQ touched a New 2-Week High of $2.46. The stock appeared on our News Catalysts scanner on Mon 22 Jun 20 at 07:38 AM in the 'BIOTECH' category. From Mon 06 Jul 20, the stock recorded 77.78% Up Days and 70.00% Green Days
About Heat Biologics, Inc. (HTBX:NASDAQ)
Heat Biologics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of novel allogeneic, 'off-the-shelf' cellular therapeutic vaccines to combat various cancers and infectious diseases.
Top 10 Gainers:
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 91.36%
- Majesco (MJCO:NASDAQ), 72.25%
- iBio, Inc. (IBIO:NYSEMKT), 63.94%
- Immuron Limited (IMRN:NASDAQ), 63.42%
- Just Energy Group Inc. (JE:NYSE), 52.46%
- Heat Biologics, Inc. (HTBX:NASDAQ), 47.15%
- Borqs Technologies, Inc. (BRQS:NASDAQ), 44.71%
- DPW Holdings, Inc. (DPW:NYSEMKT), 44.17%
- PDS Biotechnology Corporation (PDSB:NASDAQ), 39.2%
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 38.96%